IDH1 and colorectal carcinoma: Importantly, Metformin treatment has been linked to reduced CRC incidence and inhibited metastasis by downregulating pyruvatePKM2 expression and upregulating IDH1 expression, while maintaining a balance between glycolysis and oxidative phosphorylation [230].